Rachel Rau
Has grant
Associate Professor
Research Interests
Explore related searches
Contact this professor
Get a free first email built on one of their papers, ready for you to edit and send yourself.
About
Rachel Rau is an Associate Professor at Seattle Children's Hospital in the United States. Her research focuses on hematology and oncology, with recent articles exploring topics such as juvenile myelomonocytic leukemia, acute lymphoblastic leukemia, and the differentiation of hematopoietic stem cells. Dr. Rau is dedicated to enhancing patient outcomes through innovative studies and comprehensive care models in pediatric hematologic disorders.
Recent Grants
Grant: Close
Defining the Role of IKZF1 deletions in pediatric Ph+ B cell ALL
Open Date: 2017-06-01
Close Date: 2018-05-01
Grant: Close
Defining the role of DOT1L in DNMT3A-mutant leukemia
Open Date: 2017-04-01
Close Date: 2020-03-01
Grant: Close
Phase 2 Study of the JAK1/JAK2 inhibitor ruxolitinib with chemotherapy in children with DE NOVO High-Risk CRLF2-rearranged and/or JAK pathway–mutant acute lymphoblastic leukemia
Open Date: 2017-02-01
Close Date: 2024-01-01
Grant: Close
Understanding and targeting the epigenetic perturbations of IKZF1-deleted B cell ALL
Open Date: 2016-01-01
Close Date: 2017-12-01
Grant: Close
DOT1L in DNMT3A-mutant leukemia
Open Date: 2016-01-01
Close Date: 2017-12-01
Articles (20)
Year:
2024
Year:
2024
Year:
2024
Year:
2024
Recent studies suggest that chromosomal cohesin complex proteins are important in regulating hematopoiesis and may contribute to myeloid malignancies. To investigate the effects of perturbing the cohesin subunit protein RAD21 on normal hematopoiesis, we used conditional knockout (cKO) mouse models. While cohesin is vital for hematopoietic stem cell (HSC) function, Rad21 haploinsufficiency (Rad21Δ/+) led to distinct hematopoietic phenotypes. Our findings revealed that Rad21Δ/+ cells exhibited decreased hematopoietic reconstitution in competitive bone marrow transplantation assays. This reduction in peripheral blood chimerism was specifically observed in the lymphoid compartment, while the chimerism in the myeloid compartment remained unaffected. Rad21 haploinsufficiency also resulted in changes in the hematopoietic stem and progenitor cells (HSPC) and myeloid progenitor compartments, with a significant accumulation of granulocyte-macrophage progenitors in the bone marrow. We observed differential gene expression in Rad21Δ/+ LSK (Lin− Sca1−Kit+) cells, including genes required for HSPC function and differentiation, such as Setdb1, Hmga2, Ncor1, and Myb. In addition, we observed a notable decrease in the expression of genes related to the interferon response and a significant reduction in the expression of genes involved in the IL2-STAT5 signaling pathways. Our studies suggest that RAD21 protein and level of its post-translational modifications in the bone marrow cells may play a potential role in hematopoiesis. Overall, Rad21 haploinsufficiency impairs hematopoietic differentiation and increases HSC self-renewal.
Year:
2023
Year:
2023
Year:
2023
Year:
2023
Year:
2023
Year:
2023
Year:
2021
Year:
2021
Year:
2021
Year:
2021
Year:
2021
Year:
2021
Year:
2020
Year:
2020
Year:
2020
Year:
2020
Collaborators (13)
Sumit Gupta
University of Toronto
Lorenzo Brunetti
Assistant Professor
Università Politecnica delle Marche
Mignon L. Loh
University of California
Luke D. Maese
-
Reuven Schore
George Washington University
Jennifer McNeer
Professor
University of Utah
Karen Rabin
Professor
Baylor College of Medicine
Shannon Conneely
Baylor College of Medicine
Ling Liu
Associate professor
University of California, Los Angeles
Sinjini Gupta
Baylor College of Medicine
Debananda Pati
Baylor College of Medicine
Michael Kyba
University of Minnesota
Thomas Rando
Professor
University of California
Make your next move.
Prepare your application
Review drafts before you send them.